Rudy Padua, PhD, recently joined St. Teresa Medical as director of clinical affairs to oversee the ORTHOCLOT human trials.
Dr. Padua has 156 years of experience in the medical device industry. He has participated in research projects to administer preclinical studies as well as pre- and post-market clinical studies.
St. Teresa is moving forward with commercialization of its new hemostatic technology platform — ORTHOCLOT — and Dr. Padua will play a central role in developing and executing the clinical plan and procedures for the human trial in Europe.